FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robb Wilentz

Research Profile

Disorders

Chemicals & Drugs

Procedures

Immunohistochemistry

Genes & Molecular Sequences

Anatomy

Concepts & Ideas

Precancerous Conditions

Physiology

Co-author Network

Publications

TOP 3
Daniel S Longnecker; N Volkan Adsay; Carlos Fernandez-Del Castillo; Ralph Hruban; Tsutomu Kasugai; David S Klimstra; Günter Klöppel; Jutta Lüttges; Vincent A Memoli; Tor D Tosteson; Akio Yanagisawa; Robb E Wilentz; GIUSEPPE ZAMBONI
Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: interobserver agreement.
Fikret Sahin; Wanglong Qiu; Robb E Wilentz; Christine A Iacobuzio-Donahue; Andres Grosmark; Gloria H Su
RPL38, FOSL1, and UPP1 are predominantly expressed in the pancreatic ductal epithelium.
Dengfeng Cao; Robb E Wilentz; James L Abbruzzese; Linus Ho; Anirban Maitra
Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robb Wilentz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Daniel S Longnecker; N Volkan Adsay; Carlos Fernandez-Del Castillo; Ralph Hruban; Tsutomu Kasugai; David S Klimstra; Günter Klöppel; Jutta Lüttges; Vincent A Memoli; Tor D Tosteson; Akio Yanagisawa; Robb E Wilentz; GIUSEPPE ZAMBONI
Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: interobserver agreement.
Pancreas 2005;31(4):344-9.
2005: Fikret Sahin; Wanglong Qiu; Robb E Wilentz; Christine A Iacobuzio-Donahue; Andres Grosmark; Gloria H Su
RPL38, FOSL1, and UPP1 are predominantly expressed in the pancreatic ductal epithelium.
Pancreas 2005;30(2):158-67.
2005: Dengfeng Cao; Robb E Wilentz; James L Abbruzzese; Linus Ho; Anirban Maitra
Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.
International journal of gastrointestinal cancer 2005;36(1):39-46.
2005: Donna E Hansel; Raheela Ashfaq; Ayman Rahman; Dana Wanzer; Charles J Yeo; Robb E Wilentz; Anirban Maitra
A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment.
American journal of clinical pathology 2005;123(1):28-35.
2005: Donna E Hansel; Ayman Rahman; Robb E Wilentz; Ie-Ming Shih; Michael T McMaster; Charles J Yeo; Anirban Maitra
HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract.
International journal of gastrointestinal cancer 2005;35(1):15-23.
2005: Robb E Wilentz; Ayman Rahman; Pedram Argani; Christine A Iacobuzio-Donahue
Immunohistochemistry and in situ hybridization in pancreatic neoplasia.
Methods in molecular medicine 2005;103():67-88.
2005: Ralph Hruban; Robb E Wilentz; Anirban Maitra
Identification and analysis of precursors to invasive pancreatic cancer.
Methods in molecular medicine 2005;103():1-13.
2004: Phillip B Storm; Violette M Renard; John L Moriarity; Betty M. Tyler; Robb E Wilentz; Henry Brem; Jon D Weingart
Systemic BCNU enhances the efficacy of local delivery of a topoisomerase I inhibitor against malignant glioma.
Cancer chemotherapy and pharmacology 2004;54(4):361-7.
2004: Donna E Hansel; Robb E Wilentz; Charles J Yeo; Richard D Schulick; Elizabeth Montgomery; Anirban Maitra
Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract.
The American journal of surgical pathology 2004;28(3):347-56.
2003: Christophe Rosty; Joseph Geradts; Norihiro Sato; Robb E Wilentz; Helen Roberts; Taylor A Sohn; John L Cameron; Charles J Yeo; Ralph Hruban; Michael Goggins
p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis.
The American journal of surgical pathology 2003;27(12):1495-501.
2003: Denis M McCarthy; Anirban Maitra; Pedram Argani; Anne E Rader; Douglas O Faigel; N Tjarda van Heek; Ralph Hruban; Robb E Wilentz
Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2003;11(3):238-43.
2003: Elizabeth Montgomery; Robb E Wilentz; Pedram Argani; Cyril Fisher; Ralph Hruban; Scott E Kern; Christoph Lengauer
Analysis of anaphase figures in routine histologic sections distinguishes chromosomally unstable from chromosomally stable malignancies.
Cancer biology & therapy 2003;2(3):248-52.
2003: John R Doty; Robb E Wilentz; Jorge D Salazar; Ralph Hruban; Duke E Cameron
Atheroembolism in cardiac surgery.
The Annals of thoracic surgery 2003;75(4):1221-6.
2003: Denis M McCarthy; Ralph Hruban; Pedram Argani; James R Howe; Kevin C Conlon; Murray F Brennan; Marianna Zahurak; Robb E Wilentz; John L Cameron; Charles J Yeo; Scott E Kern; David S Klimstra
Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2003;16(3):272-8.
2003: Joseph D Kronz; Rolando Milord; Robb E Wilentz; Edward G Weir; Stephanie R Schreiner; Jonathan I Epstein
Lesions missed on prostate biopsies in cases sent in for consultation.
The Prostate 2003;54(4):310-4.
2003: Susan C Abraham; Robb E Wilentz; Charles J Yeo; Taylor A Sohn; John L Cameron; John K Boitnott; Ralph Hruban
Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'?
The American journal of surgical pathology 2003;27(1):110-20.
2002: Pauline de la M Hall; Robb E Wilentz; Willouw de Klerk; Philippus P C Bornman
Premalignant conditions of the pancreas.
Pathology 2002;34(6):504-17.
2002: N Tjarda van Heek; Alan K Meeker; Scott E Kern; Charles J Yeo; Keith D Lillemoe; John L Cameron; G Johan A Offerhaus; Jessica L Hicks; Robb E Wilentz; Michael Goggins; Angelo M DeMarzo; Ralph Hruban; Anirban Maitra
Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia.
The American journal of pathology 2002;161(5):1541-7.
2002: N Volkan Adsay; Kambiz Merati; Aleodor Andea; Asfar S Azmi; Ralph Hruban; Robb E Wilentz; Michael Goggins; Christine Iocobuzio-Donahue; Daniel S Longnecker; David S Klimstra
The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(10):1087-95.
2002: Michael Torbenson; Spyridon Marinopoulos; Duyen T Dang; Michael A Choti; Raheela Ashfaq; Anirban Maitra; John K Boitnott; Robb E Wilentz
Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
Human pathology 2002;33(9):871-6.
2002: Michael Torbenson; Jianzhou Wang; Michael A Choti; Raheela Ashfaq; Anirban Maitra; Robb E Wilentz; John K Boitnott
Hepatocellular carcinomas show abnormal expression of fibronectin protein.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(8):826-30.
2002: Anirban Maitra; Raheela Ashfaq; Carla R Gunn; Ayman Rahman; Charles J Yeo; Taylor A Sohn; John L Cameron; Ralph Hruban; Robb E Wilentz
Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging.
American journal of clinical pathology 2002;118(2):194-201.
2002: Theresa Pluth Yeo; Ralph Hruban; Steven D Leach; Robb E Wilentz; Taylor A Sohn; Scott E Kern; Christine A Iacobuzio-Donahue; Anirban Maitra; Michael Goggins; Marcia Canto; Ross A. Abrams; Daniel Laheru; Elizabeth M Jaffee; Manuel Hidalgo; Charles J Yeo
Pancreatic cancer.
Current problems in cancer 2002;26(4):176-275.
2002: Anirban Maitra; Christine A Iacobuzio-Donahue; Ayman Rahman; Taylor A Sohn; Pedram Argani; Renee Meyer; Charles J Yeo; John L Cameron; Michael Goggins; Scott E Kern; Raheela Ashfaq; Ralph Hruban; Robb E Wilentz
Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47.
American journal of clinical pathology 2002;118(1):52-9.
2002: Michael J Swartz; Surinder Batra; Grish C Varshney; Michael A Hollingsworth; Charles J Yeo; John L Cameron; Robb E Wilentz; Ralph Hruban; Pedram Argani
MUC4 expression increases progressively in pancreatic intraepithelial neoplasia.
American journal of clinical pathology 2002;117(5):791-6.
2002: Tjarda van Heek; Anne E Rader; G Johan A Offerhaus; Denis M McCarthy; Michael Goggins; Ralph Hruban; Robb E Wilentz
K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosis.
American journal of clinical pathology 2002;117(5):755-65.
2002: Noriyoshi Fukushima; Norihiro Sato; Takashi Ueki; Christophe Rosty; Kimberly M Walter; Robb E Wilentz; Charles J Yeo; Ralph Hruban; Michael Goggins
Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
The American journal of pathology 2002;160(5):1573-81.
2002: Walter M Klein; Ralph Hruban; Andres J P Klein-Szanto; Robb E Wilentz
Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(4):441-7.
2002: Susan C Abraham; David S Klimstra; Robb E Wilentz; Charles J Yeo; Kevin Conlon; Murray F Brennan; John L Cameron; Tsung-Teh Wu; Ralph Hruban
Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.
The American journal of pathology 2002;160(4):1361-9.
2002: Gregory Seidel; Marianna Zahurak; Christine A Iacobuzio-Donahue; Taylor A Sohn; N Volkan Adsay; Charles J Yeo; Keith D Lillemoe; John L Cameron; Ralph Hruban; Robb E Wilentz
Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms: a study of 39 cases.
The American journal of surgical pathology 2002;26(1):56-63.
2001: M Tascilar; G Johan A Offerhaus; R Altink; Pedram Argani; Taylor A Sohn; Charles J Yeo; John L Cameron; Michael Goggins; Ralph Hruban; Robb E Wilentz
Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct.
American journal of clinical pathology 2001;116(6):831-7.
2001: M Tascilar; Halcyon Skinner; Christophe Rosty; Taylor A Sohn; Robb E Wilentz; G Johan A Offerhaus; V Adsay; R A Abrams; John L Cameron; Scott E Kern; Charles J Yeo; Ralph Hruban; Michael Goggins
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):4115-21.
2001: Pedram Argani; Christine A Iacobuzio-Donahue; Byungwoo Ryu; Christophe Rosty; Michael Goggins; Robb E Wilentz; S R Murugesan; Steven D Leach; Elizabeth M Jaffee; Charles J Yeo; John L Cameron; Scott E Kern; Ralph Hruban
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):3862-8.
2001: Ralph Hruban; Christine A Iacobuzio-Donahue; Robb E Wilentz; Michael Goggins; Scott E Kern
Molecular pathology of pancreatic cancer.
Cancer journal (Sudbury, Mass.) 2001;7(4):251-8.
2001: Denis M McCarthy; Daniel J Brat; Robb E Wilentz; Charles J Yeo; John L Cameron; Scott E Kern; Ralph Hruban
Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling.
Human pathology 2001;32(6):638-42.
2001: Pedram Argani; Christophe Rosty; Robert E Reiter; Robb E Wilentz; S R Murugesan; Steven D Leach; Byungwoo Ryu; Halcyon Skinner; Michael Goggins; Elizabeth M Jaffee; Charles J Yeo; John L Cameron; Scott E Kern; Ralph Hruban
Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.
Cancer research 2001;61(11):4320-4.
2001: Robb E Wilentz; Pedram Argani; Ralph Hruban
Loss of heterozygosity or intragenic mutation, which comes first?
The American journal of pathology 2001;158(5):1561-3.
2001: Pedram Argani; A Shaukat; Manju Kaushal; Robb E Wilentz; Gloria H Su; Taylor A Sohn; Charles J Yeo; John L Cameron; Scott E Kern; Ralph Hruban
Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts.
Cancer 2001;91(7):1332-41.
2001: Anne C Tersmette; Gloria M Petersen; G Johan A Offerhaus; F C Falatko; Kieran Brune; Michael Goggins; E Rozenblum; Robb E Wilentz; Charles J Yeo; John L Cameron; Scott E Kern; Ralph Hruban
Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3):738-44.
2001: Elizabeth Montgomery; Michael Goggins; Shaoyu Zhou; Pedram Argani; Robb E Wilentz; Manju Kaushal; S Booker; Katharine E Romans; Pankaj Bhargava; Ralph Hruban; Scott E Kern
Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects.
The American journal of pathology 2001;158(2):537-42.
2001: Robb E Wilentz
The latest in pancreatic cancer research: Lustgarten Foundation awardees present their findings.
International journal of pancreatology : official journal of the International Association of Pancreatology 2001;29(2):123-5.
2000: Christine A Iacobuzio-Donahue; Robb E Wilentz; Pedram Argani; Charles J Yeo; John L Cameron; Scott E Kern; Ralph Hruban
Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression.
The American journal of surgical pathology 2000;24(11):1544-8.
2000: Christine A Iacobuzio-Donahue; David S Klimstra; N Volkan Adsay; Robb E Wilentz; Pedram Argani; Taylor A Sohn; Charles J Yeo; John L Cameron; Scott E Kern; Ralph Hruban
Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.
The American journal of pathology 2000;157(3):755-61.
2000: Ralph Hruban; Robb E Wilentz; Scott E Kern
Genetic progression in the pancreatic ducts.
The American journal of pathology 2000;156(6):1821-5.
2000: Robb E Wilentz; Michael Goggins; Mark Redston; Victoria A Marcus; N Volkan Adsay; Taylor A Sohn; Shrihari S. Kadkol; Charles J Yeo; Michael A Choti; Marianna Zahurak; K Johnson; M Tascilar; G Johan A Offerhaus; Ralph Hruban; Scott E Kern
Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity.
The American journal of pathology 2000;156(5):1641-51.
2000: Robb E Wilentz; Christine A Iacobuzio-Donahue; Pedram Argani; Denis M McCarthy; J L Parsons; Charles J Yeo; Scott E Kern; Ralph Hruban
Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.
Cancer research 2000;60(7):2002-6.
2000: Robb E Wilentz; Gloria H Su; Jia Le Dai; A B Sparks; Pedram Argani; Taylor A Sohn; Charles J Yeo; Scott E Kern; Ralph Hruban
Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.
The American journal of pathology 2000;156(1):37-43.
1999: Robb E Wilentz; J Albores-Saavedra; Marianna Zahurak; Mark A Talamini; Charles J Yeo; John L Cameron; Ralph Hruban
Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas.
The American journal of surgical pathology 1999;23(11):1320-7.
1999: Jia Le Dai; Mieke Schutte; R K Bansal; Robb E Wilentz; A Y Sugar; Scott E Kern
Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells.
Molecular carcinogenesis 1999;26(1):37-43.
1999: Ralph Hruban; Robb E Wilentz; Michael Goggins; G Johan A Offerhaus; Charles J Yeo; Scott E Kern
Pathology of incipient pancreatic cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10 Suppl 4():9-11.
1998: Robb E Wilentz; Joseph Geradts; R Maynard; G Johan A Offerhaus; M Kang; Michael Goggins; Charles J Yeo; Scott E Kern; Ralph Hruban
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression.
Cancer research 1998;58(20):4740-4.
1998: Ralph Hruban; G Johan A Offerhaus; Scott E Kern; Michael Goggins; Robb E Wilentz; Charles J Yeo
Tumor-suppressor genes in pancreatic cancer.
Journal of hepato-biliary-pancreatic surgery 1998;5(4):383-91.
1998: Robb E Wilentz; C H Chung; PD Sturm; A Musler; Taylor A Sohn; G Johan A Offerhaus; Charles J Yeo; Ralph Hruban; RJ Slebos
K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Cancer 1998;82(1):96-103.
1997: Ralph Hruban; PD Sturm; RJ Slebos; Robb E Wilentz; A R Musler; Charles J Yeo; Taylor A Sohn; Marie-Louise F Van Velthuysen; G Johan A Offerhaus
Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients.
The American journal of pathology 1997;151(4):943-9.
1996: C H Chung; Robb E Wilentz; M M Polak; T B Ramsoekh; LA Noorduyn; Dirk J Gouma; Kees Huibregtse; G Johan A Offerhaus; RJ Slebos
Clinical significance of K-ras oncogene activation in ampullary neoplasms.
Journal of clinical pathology 1996;49(6):460-4.